Evaluating the Safety and Tolerability and Determining the PK and PD of Single Dose UB-221 in Chronic Spontaneous Urticaria
Clinical trial NCT04175704 · UNKNOWN
Trial details
- NCT number
- NCT04175704
- Sponsor
- United BioPharma
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-30
- Primary completion
- 2024-11-30
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.